Your browser doesn't support javascript.
loading
Durability of the first combined antiretroviral regimen in patients with AIDS at a reference center in Belo Horizonte, Brazil, from 1996 to 2005
Ribeiro, Flávia Andrade; Tupinambás, Unaí; Fonseca, Marise Oliveira; Greco, Dirceu Bartolomeu.
  • Ribeiro, Flávia Andrade; Universidade Federal de Minas Gerais. Medical School. BR
  • Tupinambás, Unaí; Universidade Federal de Minas Gerais. Medical School. BR
  • Fonseca, Marise Oliveira; Universidade Federal de Minas Gerais. Medical School. BR
  • Greco, Dirceu Bartolomeu; Universidade Federal de Minas Gerais. Medical School. BR
Braz. j. infect. dis ; 16(1): 27-33, Jan.-Feb. 2012. ilus, tab
Article in English | LILACS | ID: lil-614546
ABSTRACT
Finding a better first antiretroviral regimen is one of the strategies used to improve span and quality of life of HIV/AIDS patients. 891 patients were followed during 24 months or until interruption/abandonment of treatment, changing regimen or death. At the end of 6 months, 69 percent of the patients were still being treated with the first regimen, 54 percent at 12 months, 48 percent at 18 months and 39 percent at 24 months. AZT-3TC-EFV was the most prescribed regimen and with the lesser discontinuation. NNRTI regimens showed high effectiveness and durability compared to PI regimens. Irregular medication dispensation was the only risk factor for failure/interruption of treatment in multivariate analyses. Intolerance/adverse effects were mainly responsible for first regimen discontinuation, followed by abandonment/non-adherence and virologic failure. Results showed significant difference between causes of interruption of first HAART with higher percentage of intolerance/adverse effects with PI regimens and higher immunologic failure with NNRTI regimens. Even with the availability of more potent and tolerable drugs, lack of adherence to HAART and high level of adverse effects are still the most important barriers to prolonged success of treatment. This study adds relevant information about durability and effectiveness of HAART in the first decade of its use in Brazil.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: HIV Infections / Patient Compliance / Anti-HIV Agents Type of study: Etiology study / Incidence study / Observational study / Prognostic study / Risk factors Limits: Adult / Female / Humans / Male Country/Region as subject: South America / Brazil Language: English Journal: Braz. j. infect. dis Journal subject: Communicable Diseases Year: 2012 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Federal de Minas Gerais/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: HIV Infections / Patient Compliance / Anti-HIV Agents Type of study: Etiology study / Incidence study / Observational study / Prognostic study / Risk factors Limits: Adult / Female / Humans / Male Country/Region as subject: South America / Brazil Language: English Journal: Braz. j. infect. dis Journal subject: Communicable Diseases Year: 2012 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Federal de Minas Gerais/BR